Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUTORPHANOL vs CABOTEGRAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUTORPHANOL vs CABOTEGRAVIR: Safety Overview

Metric BUTORPHANOL CABOTEGRAVIR
Total FAERS Reports 462 8,304
Deaths Reported 10 144
Death Rate 2.2% 1.7%
Hospitalizations 24 428
Average Patient Age 53.9 yrs 41.7 yrs
% Female Patients 79.2% 22.1%
FDA Approval Date Approved Prior to Jan 1, 1982 Dec 20, 2021
Manufacturer Hikma Pharmaceuticals USA Inc. ViiV Healthcare Company
Route NASAL ORAL
Marketing Status Discontinued Prescription